PURE Bioscience, Inc. (PURE)

Market Cap	7.83M
Revenue (ttm)	2.06M
Net Income (ttm)	-3.65M
Shares Out	111.86M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,500
Open	0.0700
Previous Close	0.0700
Day's Range	0.0700 - 0.0700
52-Week Range	0.0600 - 0.1700
Beta	0.07
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 14, 2023

About PURE

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control,...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• IPO Date: Aug 8, 1996
• Employees: 11
• Stock Exchange: OTCMKTS
• Ticker Symbol: PURE

Financial Performance

In 2023, PURE's revenue was $1.88 million, an increase of 1.30% compared to the previous year's $1.85 million. Losses were -$3.96 million, 13.3% more than in 2022.